CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Avid Bioservices Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Avid Bioservices Inc
14191 MYFORD ROAD
Phone: (714) 508-6100p:714 508-6100 TUSTIN, CA  92780  United States Ticker: CDMOCDMO

Business Summary
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services. The Company’s services include clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization. It provides fully integrated and customized biomanufacturing services that support its customers from the early preclinical stage to commercial launch and supply.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
10/31/20234/30/2023YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board JosephCarleone 77 11/1/2017 11/1/2017
President, Chief Executive Officer, Director Nicholas S.Green 59 7/30/2020 7/30/2020
Chief Financial Officer Daniel R.Hart 49 8/1/2018 8/1/2018
9 additional Officers and Directors records available in full report.

Business Names
Business Name
CDMO
Peregrine (Beijing) Pharmaceutical Technology Ltd.
Peregrine Pharmaceuticals, Inc.
PPHM
Vascular Targeting Technologies, Inc.

General Information
Number of Employees: 365 (As of 4/30/2023)
Outstanding Shares: 63,239,238 (As of 11/27/2023)
Shareholders: 605
Stock Exchange: NASD
Federal Tax Id: 953698422
Fax Number: (714) 838-5817
Email Address: info@peregrineinc.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024